Alairion, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 6
Rang # Quantité totale PI 256 877
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 195 117

Brevets

Marques

1 0
1 0
4 0
0
 
Dernier brevet 2021 - 3-(4-(11h-dibenzo[b,e][1,4]azepi...
Premier brevet 2020 - A receptor

Derniers inventions, produits et services

2020 Invention 3-(4-(11h-dibenzo[b,e][1,4]azepin-6-yl)piperazin-1-yl)- and 3-(4-(dibenzo[b,f][1,4]oxazepin/thiaz...
Invention Piperazine substituted azapine derivatives and uses thereof. The present disclosure relates to co...
Invention A receptor. AA positive allosteric modulator or pharmaceutically acceptable salt thereof to a sub...
Invention Methods for treating sleep fragmentation disorders. 2A2A11BB receptor agonist, or pharmaceuticall...
Invention 2a inverse agonist/antagonists. 12A2A antagonist or inverse activity, or pharmaceutically accepta...